Nanoscale Coatings for Ultralow Dose BMP‐2‐Driven Regeneration of Critical‐Sized Bone Defects

While new biomaterials for regenerative therapies are being reported in the literature, clinical translation is slow. Some existing regenerative approaches rely on high doses of growth factors, such as bone morphogenetic protein‐2 (BMP‐2) in bone regeneration, which can cause serious side effects. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zhe A., Alba‐Perez, Andres, Gonzalez‐Garcia, Cristina, Donnelly, Hannah, Llopis‐Hernandez, Virginia, Jayawarna, Vineetha, Childs, Peter, Shields, David W., Cantini, Marco, Ruiz‐Cantu, Laura, Reid, Andrew, Windmill, James F. C., Addison, Elena S., Corr, Sandra, Marshall, William G., Dalby, Matthew J., Salmeron‐Sanchez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343071/
https://www.ncbi.nlm.nih.gov/pubmed/30693176
http://dx.doi.org/10.1002/advs.201800361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343071/
https://www.ncbi.nlm.nih.gov/pubmed/30693176
http://dx.doi.org/10.1002/advs.201800361

Ejemplares similares